Andrew R Allen Epizyme, Inc. (EPZM) insider trading activity

EPZM Quotes by TradingView

Andrew R Allen is Director of Epizyme, Inc.. Currently has a direct ownership of 20,560 shares of EPZM, which is worth approximately $0. The most recent transaction as insider was on Jun 11, 2021, when has been sold 8,060 shares (Common Stock, par value $0.0001) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.6K
0% 3M change
0% 12M change
Total Value Held $0

Andrew R Allen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2021
BUY
Grant, award, or other acquisition
-
8,060 Added 28.16%
20,560 Common Stock, par valu...

Also insider at

ADAP
Adaptimmune Therapeutics PLC Healthcare
Director
GRTS
Gritstone bio, Inc. Healthcare
PRESIDENT AND CEO
TCRR
TCR2 THERAPEUTICS INC. Healthcare
Director
SRRA
Sierra Oncology, Inc. Healthcare
Director
ARA

Andrew R Allen

Director
Cambridge, MA

Track Institutional and Insider Activities on EPZM

Follow Epizyme, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EPZM shares.

Notify only if

Insider Trading

Get notified when an Epizyme, Inc. insider buys or sells EPZM shares.

Notify only if

News

Receive news related to Epizyme, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EPZM